Application of periplaneta americana polypeptide and periplaneta americana peptide A as immunologic adjuvant

CN119564848APending Publication Date: 2025-03-07DALI UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411777418.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-12-05
Publication Date
2025-03-07

Smart Images

  • Figure CN119564848A_ABST
    Figure CN119564848A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biomedicine, and particularly relates to application of periplaneta americana polypeptide periplaneta americana peptide A as an immunologic adjuvant. The amino acid sequence of the periplaneta americana polypeptide periplaneta americana peptide A is shown as SEQ ID NO.1. The invention further discloses a preparation method of the periplaneta americana polypeptide periplaneta americana peptide A. According to the invention, influenza virus H1N1RBD protein is matched with periplaneta americana peptide A to induce mice to generate an anti-RBD protein specific IgG antibody with higher titer, and the titer is increased along with the increase of immunization times, so that the immunopotentiation effect is achieved, and mass production can be facilitated. The periplaneta americana polypeptide and periplaneta americana peptide A can be conveniently and massively synthesized and obtained, and can be used as a novel micromolecular immune adjuvant to enhance the specific immune response of an organism.
Need to check novelty before this filing date? Find Prior Art